WithdrawnNCT00788385Updated Apr 14, 2015

Multi-Center Study of ShuntCheck

A Phase 4 interventional study of ShuntCheck test in Blocked Ventricular Shunts, sponsored by NeuroDx Development. Withdrawn. Open to participants aged 1 Month to 19 Years. Per ClinicalTrials.gov, last updated 2015-04-14.

Sponsored by NeuroDx Development · Phase 4, Interventional, and Diagnostic

Why this study was withdrawn

Insufficient funding

Phase: Phase 4
Study type: Interventional
Enrollment: 0
Allocation: Not applicable
Ages: 1 Month to 19 Years
Sex: All

Study summary

Multi-Center Study of ShuntCheck

Conditions studied

Blocked Ventricular Shunts

Keywords

Hydrocephalus
High Pressure
Shunt Blockage

In context

Lead sponsor

NeuroDx Development is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 1 Month to 19 Years
Sexes eligible: All
Accepts healthy volunteers: No

Eligibility criteria

Inclusion Criteria:

Exclusion Criteria:

Study design

Phase: Phase 4
Primary purpose: Diagnostic
Allocation: Not applicable
Intervention model: Single group
Masking: Double (Participant, Investigator)
Enrollment: 0 participants (actual)

Interventions

DeviceShuntCheck test

Study locations

No study locations are listed for this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Apr 14, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT00788385
Lead sponsor: NeuroDx Development
First posted: Nov 10, 2008
Start date: Jun 2009
Primary completion: Jun 2010 (estimated)
Completion: Dec 2010 (estimated)
Last update: Apr 14, 2015

Oversight

Data monitoring committee: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

NeuroDx Development

Start the discussion